(Q34291204)

1 August 2017

1 reference

title

The role of leukotriene receptor antagonists in the treatment of chronic asthma in childhood (English)

1 reference

1 August 2017

0 references

Warner JO

1

1 reference

1 August 2017

publication date

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

56 Suppl 66

1 reference

1 August 2017

page(s)

22-29

1 reference

Changes in asthma prevalence: two surveys 15 years apart

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Review of prescribed treatment for children with asthma in 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

21 January 2018

Asthma and inflammation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

The complexity of treatment adherence in adults with asthma: challenges and opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

A comparison of the efficacy and safety of inhaled corticosteroids in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Efficacy and safety of inhaled corticosteroids. New developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Treatment of asthma with drugs modifying the leukotriene pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Enhanced arachidonic acid metabolism in alveolar macrophages from wheezy infants. Modulation by dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Churg-Strauss Syndrome in Patients Receiving Montelukast as Treatment for Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Bronchoalveolar Cell Profiles in Children with Asthma, Infantile Wheeze, Chronic Cough, or Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

Childhood asthma and lung function in mid-adult life

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

7 January 2021

Prognosis of asthma from childhood to adulthood

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

7 January 2021

Bronchoalveolar lavage findings suggest two different forms of childhood asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

7 January 2021

Noncompliance and treatment failure in children with asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

7 January 2021

Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

7 January 2021

Inhaled corticosteroid use and bone-mineral density in patients with asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

7 January 2021

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

7 January 2021

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

7 January 2021

Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

7 January 2021

Antileukotriene drugs in the management of asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

7 January 2021

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

7 January 2021

Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

7 January 2021

Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

7 January 2021

Leukotrienes and histamine mediate IgE-dependent contractions of human bronchi: pharmacological evidence obtained with tissues from asthmatic and non-asthmatic subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

1 reference

7 January 2021

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

7 January 2021

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

7 January 2021

Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

7 January 2021

Seven cases of complete and incomplete forms of Churg-Strauss syndrome not related to leukotriene receptor antagonists

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00005.X

7 January 2021

10.1034/J.1398-9995.2001.00005.X

Identifiers

DOI

1 reference

1 August 2017

1 reference